Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1995;26:1859-1866

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, A.

(Stroke. 1995;26:1859-1866.)
© 1995 American Heart Association, Inc.


Articles

Amino Acid Uptake in Ischemically Compromised Brain Tissue

Andreas Jacobs, MD

From the Max-Planck-Institut für neurologische Forschung and Neurologische Universitätsklinik Köln, Köln, Germany.

Correspondence to Dr A. Jacobs, Max-Planck-Institut für neurologische Forschung and Neurologische Universitätsklinik Köln, Josef-Stelzmann-Strasse 9, D-50931 Köln, Germany.

Background and Purpose Multitracer positron emission tomography (PET) was used to investigate local amino acid accumulation in brain tissue surrounding focal ischemia.

Methods PET using 15O-labeled oxygen and water for measuring cerebral metabolic rate of oxygen (CMRO2) and cerebral blood flow (CBF), C15O for determination of blood volume (CBV) and calculation of oxygen extraction fraction, and L-[11C]methylmethionine (11C-MET) for the assessment of amino acid accumulation was applied in 14 patients (mean age, 52±9.1 years) with acute ischemic hemispheric stroke. Two multitracer PET studies were completed, the first 8 to 24 hours after onset of neurological symptoms and the follow-up study 14±1 days after the ischemic attack. Functional changes were compared with morphological damage on cranial CT or MRI. Three-dimensional matching and volume of interest evaluation procedures were used to study 11C-MET accumulation in relation to various physiological variables in infarcted and noninfarcted tissue.

Results Compared with contralateral mirror regions, initially increased regional 11C-MET uptake (21.2±10.9%, P<.001) was found in patchy areas in the immediate vicinity of infarction as well as in distant areas within the same hemisphere. In those areas, regional CBF (-11.4±21.2%, P<.01) and oxygen extraction fraction (2.8±29.1%, P=NS) were highly variable, and regional CMRO2 was preserved or slightly reduced (-12.4±16.0%, P<.001). CBF data comprised severely ischemic as well as high values (14.6 to 64.2 mL/100 g per minute). Cranial CT and coregistered MRI in five patients demonstrated preserved morphology. In all peri-infarct areas (n=62), the 11C-MET uptake showed a positive correlation with {Delta}CMRO2 as the relative improvement of ipsilateral CMRO2 between the two PET studies (r=.378, P<.01). Particularly in areas with increased oxygen extraction fraction (n=42), the 11C-MET uptake showed a mild correlation with CMRO2 at follow-up measurement (r=.31, P<.05). In all peri-infarct areas, 11C-MET uptake showed a negative correlation with oxygen extraction fraction (r=-.672, P<.001) and a positive correlation with CBF (r=.4, P=.001). In all infarcted and peri-infarct areas, normalized initial 11C-MET uptake was positively correlated with CMRO2 at follow-up (r=.603, P<.001).

Conclusions Focal increases of 11C-MET uptake seen in this study were generally mild. They might be seen in the core of ischemia, indicating breakdown of the blood-brain barrier with poor tissue prognosis, but they also frequently occurred during or after ischemic compromise in surviving brain tissue surrounding focal cerebral infarction, perhaps representing alterations of amino acid transport or protein synthesis in brain tissue with a favorable prognosis.


Key Words: amino acids • cerebral ischemia, focal • tomography, emission-computed • protein synthesis




This article has been cited by other articles:


Home page
JNMHome page
M. Morooka, K. Kubota, H. Kadowaki, K. Ito, O. Okazaki, M. Kashida, T. Mitsumoto, R. Iwata, K. Ohtomo, and M. Hiroe
11C-Methionine PET of Acute Myocardial Infarction
J. Nucl. Med., August 1, 2009; 50(8): 1283 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Ceyssens, K. Van Laere, T. de Groot, J. Goffin, G. Bormans, and L. Mortelmans
[11C]Methionine PET, Histopathology, and Survival in Primary Brain Tumors and Recurrence
AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1432 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P. V. Madakasira, R. Simkins, T. Narayanan, K. Dunigan, R. J. Poelstra, and J. Mantil
Cortical Dysplasia Localized by [11C]Methionine Positron Emission Tomography: Case Report
AJNR Am. J. Neuroradiol., May 1, 2002; 23(5): 844 - 846.
[Abstract] [Full Text] [PDF]